Lataa...
Effect of meal timing on pharmacokinetics and pharmacodynamics of tegoprazan in healthy male volunteers
ABSTRACT: Tegoprazan, a novel potassium‐competitive acid blocker, is used to treat acid‐related diseases. However, there is no information on the pharmacokinetic (PK) and pharmacodynamic (PD) profiles of the marketed dosage of tegoprazan under various meal timings in a fed and fasted state. The stud...
Tallennettuna:
| Julkaisussa: | Clin Transl Sci |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8212751/ https://ncbi.nlm.nih.gov/pubmed/33382926 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cts.12958 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|